Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jun 28, 2023; 29(24): 3855-3870
Published online Jun 28, 2023. doi: 10.3748/wjg.v29.i24.3855
Figure 3
Figure 3 The correlation between the optimal variables and thalidomide-induced peripheral neuropathy. Illustrate patients with interleukin-12 rs1353248_TT, brain-derived neurotrophic factor (BDNF) rs2030324_AG, BDNF rs6265_CT, and BDNF rs11030104_AG, genotypes are more likely to have thalidomide-induced peripheral neuropathy than non-carriers. A: IL-12; B-D: BDNF. aP < 0.01, bP < 0.001. BDNF: Brain-derived neurotrophic factor; IL: Interleukin.